Your browser doesn't support javascript.
loading
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator.
Cingolani, Linda; Barberio, Brigida; Zingone, Fabiana; Ferronato, Antonio; Bertani, Lorenzo; Costa, Francesco; Bodini, Giorgia; Demarzo, Maria Giulia; Melatti, Piera; Gubbiotti, Alessandro; Massimi, Davide; Casadei, Cesare; D'Incà, Renata; Savarino, Edoardo Vincenzo.
Afiliación
  • Cingolani L; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
  • Barberio B; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
  • Zingone F; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy. fabiana.zingone@unipd.it.
  • Ferronato A; Endoscopy Unit, Alto Vicentino Hospital, AULSS7, Pedemontana, Italy.
  • Bertani L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Costa F; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Bodini G; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
  • Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
  • Melatti P; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
  • Gubbiotti A; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
  • Massimi D; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
  • Casadei C; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
  • D'Incà R; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
  • Savarino EV; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Sci Rep ; 11(1): 10368, 2021 05 14.
Article en En | MEDLINE | ID: mdl-33990652
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Sustitución de Medicamentos / Biosimilares Farmacéuticos / Adalimumab Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Sustitución de Medicamentos / Biosimilares Farmacéuticos / Adalimumab Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido